ArticleCell reports. Medicine2023

Immunotherapy targeting B cells and long-lived plasma cells effectively eliminates pre-existing donor-specific allo-antibodies.

Zheng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.